Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial

Parkinsonism Relat Disord. 2018 Sep;54:110-112. doi: 10.1016/j.parkreldis.2018.04.003. Epub 2018 Apr 4.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology*
  • Double-Blind Method
  • Female
  • Gastrointestinal Microbiome / drug effects*
  • Humans
  • Intestinal Diseases / drug therapy*
  • Intestinal Diseases / etiology
  • Intestinal Diseases / microbiology*
  • Intestine, Small / microbiology*
  • Male
  • Middle Aged
  • Parkinson Disease / complications
  • Parkinson Disease / microbiology*
  • Rifaximin / administration & dosage
  • Rifaximin / adverse effects
  • Rifaximin / pharmacology*
  • Treatment Failure

Substances

  • Anti-Bacterial Agents
  • Rifaximin